Caption Management »

Karyopharm Therapeutics shares owned by Caption Management

Quarter-by-quarter ownership of Karyopharm Therapeutics (KPTI) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in Karyopharm Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Karyopharm Therapeutics held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Karyopharm Therapeutics by Caption Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.6M 1.2M 5.57

More positions owned by Caption Management

Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
United Therapeutics Corporation (UTHR)
Carvana Cl A Call Option (CVNA)
Warner Bros Discovery Com Ser A Call Option (WBD)
Amazon (AMZN)
Blue Owl Capital Com Cl A (OWL)
Electronic Arts Call Option (EA)
Tesla Motors (TSLA)
Take-Two Interactive Software (TTWO)
Spdr Series Trust State Street Spd Call Option (XBI)
UnitedHealth (UNH)
Netflix (NFLX)
Cg Oncology (CGON)
Microsoft Corporation (MSFT)

View all positions for Caption Management

Top funds holding Karyopharm Therapeutics

Ikarian Capital
Commodore Capital
RA Capital Management
Adage Capital Partners GP
T. Rowe Price Investment Management
Susquehanna International
Caption Management
Goldman Sachs Group
Catalio Capital Management
Boothbay Fund Management
Squadron Capital Management
Vanguard Capital Management
Jane Street
Vanguard Group
Millennium Management

View all funds holding Karyopharm Therapeutics